Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Selzer

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|May 9, 2022
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N<sup>1</sup> -Methylnicotinamide: A PBPK Modeling ApproachDenise Türk, Fabian Müller, Martin F Fromm, et al.
Infectious Disease Modelling|January 8, 2026
Integrating Kolmogorov-Arnold networks with ordinary differential equations for efficient, interpretable, and robust deep learning: Epidemiology of infectious diseases as a case studyKexin Ma, Xu Lu, Nicola Luigi Bragazzi, et al.
Pharmaceutics|August 26, 2022
Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and RisperidoneSimeon Rüdesheim, Dominik Selzer, Thomas Mürdter, et al.
Pharmaceutics|May 28, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction PredictionsHelena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, et al.
Advanced Drug Delivery Reviews|July 4, 2012
Finite and infinite dosing: difficulties in measurements, evaluations and predictionsDominik Selzer, Mona M A Abdel-Mottaleb, Tsambika Hahn, et al.
Pharmaceutics|June 27, 2020
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm NeonatesLukas Kovar, Christina Schräpel, Dominik Selzer, et al.
Pharmaceutics|July 27, 2022
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction ModelingLaura Maria Fuhr, Fatima Zahra Marok, Maximilian Mees, et al.
Pharmaceutics|December 16, 2020
Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene InteractionsSimeon Rüdesheim, Jan-Georg Wojtyniak, Dominik Selzer, et al.
Experimental Dermatology|March 3, 2012
Influence of the application area on finite dose permeation in relation to drug type appliedTsambika Hahn, Dominik Selzer, Dirk Neumann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 30, 2015
A strategy for in-silico prediction of skin absorption in manDominik Selzer, Dirk Neumann, Heike Neumann, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|May 9, 2022
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N<sup>1</sup> -Methylnicotinamide: A PBPK Modeling ApproachDenise Türk, Fabian Müller, Martin F Fromm, et al.
Infectious Disease Modelling|January 8, 2026
Integrating Kolmogorov-Arnold networks with ordinary differential equations for efficient, interpretable, and robust deep learning: Epidemiology of infectious diseases as a case studyKexin Ma, Xu Lu, Nicola Luigi Bragazzi, et al.
Pharmaceutics|August 26, 2022
Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and RisperidoneSimeon Rüdesheim, Dominik Selzer, Thomas Mürdter, et al.
Pharmaceutics|May 28, 2022
Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction PredictionsHelena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, et al.
Advanced Drug Delivery Reviews|July 4, 2012
Finite and infinite dosing: difficulties in measurements, evaluations and predictionsDominik Selzer, Mona M A Abdel-Mottaleb, Tsambika Hahn, et al.
Pharmaceutics|June 27, 2020
Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm NeonatesLukas Kovar, Christina Schräpel, Dominik Selzer, et al.
Pharmaceutics|July 27, 2022
A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug-Drug Interaction ModelingLaura Maria Fuhr, Fatima Zahra Marok, Maximilian Mees, et al.
Pharmaceutics|December 16, 2020
Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene InteractionsSimeon Rüdesheim, Jan-Georg Wojtyniak, Dominik Selzer, et al.
Experimental Dermatology|March 3, 2012
Influence of the application area on finite dose permeation in relation to drug type appliedTsambika Hahn, Dominik Selzer, Dirk Neumann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 30, 2015
A strategy for in-silico prediction of skin absorption in manDominik Selzer, Dirk Neumann, Heike Neumann, et al.
Pageof 5